John J. Orloff - 08 Jun 2021 Form 4 Insider Report for ALEXION PHARMACEUTICALS, INC.

Role
EVP, Research & Development
Signature
/s/ Douglas Barry, Attorney-in-Fact for John Orloff
Issuer symbol
N/A
Transactions as of
08 Jun 2021
Net transactions value
-$346,389
Form type
4
Filing time
09 Jun 2021, 16:53:56 UTC
Next filing
16 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXN Common Stock, par value $.0001 per share Tax liability $346,389 -1,957 -2.2% $177.00 86,367 08 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.